GoHearing Ultra vs Sony CRE-C20
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

GoHearing Ultra
The GoHearing Ultra is a budget-priced OTC behind-the-ear hearing aid that earned a B grade with a SoundScore of 3.1/5 in our lab testing. At $499, it sits in the most affordable tier of OTC devices, though its overall performance ranks 58th out of 65 OTC hearing aids tested. This device shows a distinctive performance profile with notable strengths in specific areas. Feedback handling earned an excellent 5.0/5, scoring 0.46 points above the category average—meaning users are unlikely to experience whistling or squealing during typical use. Music streaming also performed well at 3.6/5, a solid score that sits 1.68 points above the OTC average of 1.92/5, making it a reasonable choice for those who prioritize phone audio streaming. However, the GoHearing Ultra struggles in core speech understanding metrics. Speech in quiet scored just 1.0/5, falling 1.79 points below the category average, while speech in noise also scored 1.0/5, sitting 0.48 points below average. Own-voice comfort measured 1.9/5, which is 0.61 points below the typical OTC device. These low speech scores significantly limit the device's utility for its primary purpose of improving conversation clarity. Consumers seeking better overall value in this price range may want to consider alternatives like the Elehear Beyond (4.36/5) or Apple AirPods Pro 2 (4.06/5), which deliver substantially stronger speech performance. The GoHearing Ultra may suit buyers who prioritize streaming audio and feedback-free wear over speech enhancement, but those seeking meaningful speech benefit should explore higher-performing options.

Sony CRE-C20
The Sony CRE-C20 is an invisible-in-ear OTC hearing aid priced at $999, earning a B grade with a SoundScore of 3.6/5 in our lab testing. This mid-priced device offers a discreet form factor with rechargeable batteries, positioning it in the upper tier of the OTC market. In our testing, the CRE-C20 demonstrates notable strengths in speech clarity. Speech in quiet scores 4.1/5—a strong result that sits 1.33 points above the OTC category average. Speech in noise performance reaches 2.7/5, which is 1.24 points above the category average, though only mixed in absolute terms. Own voice comfort scores 2.9/5, slightly above average for the category at +0.39 points. The device shows significant limitations in other areas. Music streaming scored 0.0/5, falling 1.92 points below the category average—this invisible-in-ear design does not support audio streaming functionality. Feedback handling registers at 3.9/5, which is solid in absolute terms, though 0.64 points below the category average of 4.54/5. The CRE-C20 demonstrates meaningful improvement with proper adjustment. The normalized Initial Score of 3.4/5 improves to 4.2/5 when tuned, suggesting users who invest time in optimization will see better results. Within its price range, alternatives like the Sony CRE-E10 (4.69/5) and Lexie B2 Plus (4.43/5) score higher overall. The CRE-C20 is best suited for users prioritizing discretion and speech clarity who don't need music streaming capabilities.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit